Inhibiting anti-angiogenic VEGF165b activates a miR-17-20a-Calcipressin-3 pathway that revascularizes ischemic muscle in peripheral artery disease.
Sonia BatanSivaraman KuppuswamyMadison WoodMeghana ReddyBrian H AnnexVijay C GantaPublished in: Communications medicine (2024)
b-inhibition in PAD.